225 related articles for article (PubMed ID: 8592670)
1. Nebulization of fluids of different physicochemical properties with air-jet and ultrasonic nebulizers.
McCallion ON; Taylor KM; Thomas M; Taylor AJ
Pharm Res; 1995 Nov; 12(11):1682-8. PubMed ID: 8592670
[TBL] [Abstract][Full Text] [Related]
2. The influence of fluid physicochemical properties on vibrating-mesh nebulization.
Ghazanfari T; Elhissi AM; Ding Z; Taylor KM
Int J Pharm; 2007 Jul; 339(1-2):103-11. PubMed ID: 17451896
[TBL] [Abstract][Full Text] [Related]
3. Factors affecting aerosol performance during nebulization with jet and ultrasonic nebulizers.
Steckel H; Eskandar F
Eur J Pharm Sci; 2003 Aug; 19(5):443-55. PubMed ID: 12907295
[TBL] [Abstract][Full Text] [Related]
4. Impact of lyoprotectants for the stabilization of biodegradable nanoparticles on the performance of air-jet, ultrasonic, and vibrating-mesh nebulizers.
Beck-Broichsitter M; Kleimann P; Schmehl T; Betz T; Bakowsky U; Kissel T; Seeger W
Eur J Pharm Biopharm; 2012 Oct; 82(2):272-80. PubMed ID: 22820646
[TBL] [Abstract][Full Text] [Related]
5. Aerosolization potential of cyclodextrins--influence of the operating conditions.
Le VN; Leterme P; Gayot A; Flament MP
PDA J Pharm Sci Technol; 2006; 60(5):314-22. PubMed ID: 17089700
[TBL] [Abstract][Full Text] [Related]
6. Physicochemical aspects and efficiency of albuterol nebulization: comparison of three aerosol types in an in vitro pediatric model.
Sidler-Moix AL; Di Paolo ER; Dolci U; Berger-Gryllaki M; Cotting J; Pannatier A
Respir Care; 2015 Jan; 60(1):38-46. PubMed ID: 25516995
[TBL] [Abstract][Full Text] [Related]
7. Effect of nebulizer type and antibiotic concentration on device performance.
Weber A; Morlin G; Cohen M; Williams-Warren J; Ramsey B; Smith A
Pediatr Pulmonol; 1997 Apr; 23(4):249-60. PubMed ID: 9141110
[TBL] [Abstract][Full Text] [Related]
8. Design principles of liquid nebulization devices currently in use.
Rau JL
Respir Care; 2002 Nov; 47(11):1257-75; discussion 1275-8. PubMed ID: 12425742
[TBL] [Abstract][Full Text] [Related]
9. Inhalation of tobramycin in cystic fibrosis. Part 1: the choice of a nebulizer.
Le Brun PP; de Boer AH; Gjaltema D; Hagedoorn P; Heijerman HG; Frijlink HW
Int J Pharm; 1999 Nov; 189(2):205-14. PubMed ID: 10536249
[TBL] [Abstract][Full Text] [Related]
10. In vitro comparison of DeVilbiss jet and ultrasonic nebulizers.
Newman SP; Pellow PG; Clarke SW
Chest; 1987 Dec; 92(6):991-4. PubMed ID: 3677844
[TBL] [Abstract][Full Text] [Related]
11. Physical properties of antibiotic aerosols produced by jet and ultrasonic nebulizers.
Takanami C; Goto Y
J Aerosol Med; 1990; 3(1):45-52. PubMed ID: 10147674
[TBL] [Abstract][Full Text] [Related]
12. Comparison of three commercial ultrasonic nebulizers.
Katial RK; Reisner C; Buchmeier A; Bartelson BB; Nelson HS
Ann Allergy Asthma Immunol; 2000 Feb; 84(2):255-61. PubMed ID: 10719784
[TBL] [Abstract][Full Text] [Related]
13. Measurement of particle and mass distribution of pentamidine aerosol by ultrasonic and air jet nebulizers.
Hager J; Gober KH; Löhr JP; Dürr M
J Aerosol Med; 1992; 5(2):65-79. PubMed ID: 10147685
[TBL] [Abstract][Full Text] [Related]
14. Droplets produced by medical nebulizers. Some factors affecting their size and solute concentration.
Phipps PR; Gonda I
Chest; 1990 Jun; 97(6):1327-32. PubMed ID: 2347217
[TBL] [Abstract][Full Text] [Related]
15. In vitro characteristics of tobramycin aerosol from ultrasonic and jet nebulizers.
Asmus MJ; Milavetz G; Tice AL; Teresi ME
Pharmacotherapy; 2001 May; 21(5):534-9. PubMed ID: 11349742
[TBL] [Abstract][Full Text] [Related]
16. Application of a droplet evaporation model to aerodynamic size measurement of drug aerosols generated by a vibrating mesh nebulizer.
Rao N; Kadrichu N; Ament B
J Aerosol Med Pulm Drug Deliv; 2010 Oct; 23(5):295-302. PubMed ID: 20455771
[TBL] [Abstract][Full Text] [Related]
17. Physical properties of aerosols produced by several jet- and ultrasonic nebulizers.
Sterk PJ; Plomp A; van de Vate JF; Quanjer PH
Bull Eur Physiopathol Respir; 1984; 20(1):65-72. PubMed ID: 6704568
[TBL] [Abstract][Full Text] [Related]
18. Albuterol delivery in an in vitro pediatric ventilator lung model: comparison of jet, ultrasonic, and mesh nebulizers.
Sidler-Moix AL; Dolci U; Berger-Gryllaki M; Pannatier A; Cotting J; Di Paolo ER
Pediatr Crit Care Med; 2013 Feb; 14(2):e98-102. PubMed ID: 23287904
[TBL] [Abstract][Full Text] [Related]
19. Characterization and in vitro evaluation of the formoterol/cyclodextrin complex for pulmonary administration by nebulization.
Thi TH; Azaroual N; Flament MP
Eur J Pharm Biopharm; 2009 May; 72(1):214-8. PubMed ID: 19010412
[TBL] [Abstract][Full Text] [Related]
20. Surface active drugs significantly alter the drug output rate from medical nebulizers.
Arzhavitina A; Steckel H
Int J Pharm; 2010 Jan; 384(1-2):128-36. PubMed ID: 19825407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
